Table 1.
Baseline characteristics of enrolled Tatelo participants (N=28).
| Birth Characteristics | |
| Female sex – no. (%) | 19 (68) |
| Gestational age at birtha – no. (%) | |
| 35 weeks | 4 (14) |
| 36 weeks | 6 (21) |
| 37 weeks | 2 (7) |
| 38–41 weeks | 16 (57) |
| Median birth weight – kg (IQR) | 2.95 (2.60–3.20) |
| Median HIV-1 RNA at birth – log10 copies/mL (IQR) | 4.09 (2.54–4.65) |
| Median HIV DNA at birth – copies/million cells (IQR)b | 490 (121–1221) |
| Maternal education, highest level attained – no. (%) | |
| None/Primary | 6 (21) |
| Junior Secondary | 13 (46) |
| Senior Secondary | 4 (14) |
| Tertiary | 5 (18) |
| Maternal employment status – no. (%) | |
| Salaried | 6 (21) |
| Paid domestic work | 2 (7) |
| None/Unemployed | 20 (71) |
| Characteristics at Time of Enrollment to Tatelo | |
| Median age – years (IQR) | 3.60 (3.10–4.46) |
| Median weight – kg (IQR) | 12.90 (11.90–15.20) |
| ART regimenc – no. | |
| ZDV+3TC+LPV/r | 26 |
| ABC+3TC+LPV/r | 1 |
| ZDV+ABC+3TC+LPV/r | 1 |
| Median CD4 count – cells/mm3 (IQR) | 1198 (843–1684) |
| Median HIV DNA (at 84/96 weeks of age) – copies/million cells (IQR) | 35.3 (8.38–102.3) |
IQR, interquartile range.
a
EIT Study excluded children born before 35 weeks gestational age.
b
Measured in PBMCs by ddPCR.
c
ZDV=zidovudine, 3TC=lamivudine, LPV/r=lopinavir/ritonavir, ABC=abacavir